Search

everythinglearnresearchcommunity

for

Search:↓

The enzyme 5α-reductase type 1 is important for blood vessel development and fertility in the uterus.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

The enzyme 5α-reductase is key in causing psychotic-like effects from sleep deprivation.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The research identified and described a gene important for hormone conversion in endangered catfish, which varies in activity during different reproductive stages and after hormone treatment.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Dutasteride may help protect neurons and reduce inflammation in Parkinson's disease.

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

Glucocorticoids and sex hormones affect skin health, with potential for targeted treatments to minimize side effects and treat skin conditions.

Male pattern hair loss is genetic and influenced by hormones, with treatments like minoxidil and surgery available.

Testosterone is crucial for development, growth, and various body functions in mammals.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Plant-based chemicals may help hair growth and prevent hair loss but need more research to compete with current treatments.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Sex-determining genes may affect male baldness.

Some plants with flavonoids may help treat hair loss and promote hair growth.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Understanding hair follicle biology and stem cell control could lead to new hair loss treatments.